Unknown

Dataset Information

0

In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.


ABSTRACT: Acinetobacter baumannii-calcoaceticus complex (ABC) organisms cause severe infections that are difficult to treat due to preexisting antibiotic resistance. Sulbactam-durlobactam (formerly sulbactam-ETX2514) (SUL-DUR) is a ?-lactam-?-lactamase inhibitor combination antibiotic designed to treat serious infections caused by ABC organisms, including multidrug-resistant (MDR) strains. The in vitro antibacterial activities of SUL-DUR and comparator agents were determined by broth microdilution against 1,722 clinical isolates of ABC organisms collected in 2016 and 2017 from 31 countries across Asia/South Pacific, Europe, Latin America, the Middle East, and North America. Over 50% of these isolates were resistant to carbapenems. Against this collection of global isolates, SUL-DUR had a MIC50/MIC90 of 1/2??g/ml compared to a MIC50/MIC90 of 8/64??g/ml for sulbactam alone. This level of activity was found to be consistent across organisms, regions, sources of infection, and subsets of resistance phenotypes, including MDR and extensively drug-resistant isolates. The SUL-DUR activity was superior to those of the tested comparators, with only colistin having similar potency. Whole-genome sequencing of the 39 isolates (2.3%) with a SUL-DUR MIC of?>4??g/ml revealed that these strains encoded either the metallo-?-lactamase NDM-1, which durlobactam does not inhibit, or single amino acid substitutions near the active site of penicillin binding protein 3 (PBP3), the primary target of sulbactam. In summary, SUL-DUR demonstrated potent antibacterial activity against recent, geographically diverse clinical isolates of ABC organisms, including MDR isolates.

SUBMITTER: McLeod SM 

PROVIDER: S-EPMC7179289 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In Vitro</i> Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-<i>calcoaceticus</i> Complex Isolates Collected Globally in 2016 and 2017.

McLeod Sarah M SM   Moussa Samir H SH   Hackel Meredith A MA   Miller Alita A AA  

Antimicrobial agents and chemotherapy 20200324 4


<i>Acinetobacter baumannii</i>-<i>calcoaceticus</i> complex (ABC) organisms cause severe infections that are difficult to treat due to preexisting antibiotic resistance. Sulbactam-durlobactam (formerly sulbactam-ETX2514) (SUL-DUR) is a β-lactam-β-lactamase inhibitor combination antibiotic designed to treat serious infections caused by ABC organisms, including multidrug-resistant (MDR) strains. The <i>in vitro</i> antibacterial activities of SUL-DUR and comparator agents were determined by broth  ...[more]

Similar Datasets

| S-EPMC10777848 | biostudies-literature
| S-EPMC11002948 | biostudies-literature
| S-EPMC10916374 | biostudies-literature
| S-EPMC9309244 | biostudies-literature
| S-EPMC10603586 | biostudies-literature
| S-EPMC8152955 | biostudies-literature
| S-EPMC4517069 | biostudies-literature
| S-EPMC6440288 | biostudies-literature
| S-EPMC4604477 | biostudies-literature
| S-EPMC5826149 | biostudies-literature